| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 10,357,000 | 14,798,000 | 23,446,000 | 22,225,000 | | Cost of Revenue | 7,464,000 | 10,613,000 | 17,345,000 | 17,128,000 | | | Gross Profit | 2,893,000 | 4,185,000 | 6,101,000 | 5,097,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,663,000 | 1,762,000 | 1,750,000 | 2,999,000 | | Non Recurring |
-
| 1,412,000 |
-
|
-
| | Others | 665,000 | 626,000 | 597,000 | 504,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 565,000 | 385,000 | 3,754,000 | 1,594,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 74,000 |
-
| (9,000) | | Earnings Before Interest And Taxes | 565,000 | 459,000 | 3,754,000 | 1,585,000 | | Interest Expense | 13,000 | 70,000 | 53,000 | 1,000 | | Income Before Tax | 552,000 | 389,000 | 3,701,000 | 1,584,000 | | Income Tax Expense | 270,000 | 430,000 | 1,637,000 | 810,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 282,000 | (41,000) | 2,064,000 | 774,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 282,000 | (41,000) | 2,064,000 | 774,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $282,000 | ($41,000) | $2,064,000 | $774,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
